Chimeric antigen receptor (CAR) T cells

Learning Objectives

At the end of this course, attendees will be able to: 
  • Describe the fundamental concepts of how a CAR T cell works 
  • Understand the basic nonclinical assessments of CAR T therapy in support of clinical development 
  • Understand considerations applied for clinical trial design of cell therapies 
  • Recognize the gaps and needs for future CAR T development in the field of Oncology 
Course summary
Course opens: 
03/22/2022
Course expires: 
03/23/2027
Cost:
$25.00
Part of: 
Therapeutic Modalities
Rating: 
0
Cori Abikoff
TITLE
Takeda Pharmaceuticals International Co.
 
Lauren Gauthier, MS, PhD
Scientific Director, Drug Safety Therapeutic Area Lead of Oncology and Cell Therapy
Takeda Pharmaceuticals International Co.
 

Price

Cost:
$25.00
Please login or register to take this course.